A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
- Author
- BAUR, Martina1 2 ; VAN OOSTEROM, Allan T3 ; DIERAS, Veronique4 ; TUBIANA-HULIN, Michele5 ; COOMBES, R. Charles6 ; HATSCHEK, Thomas7 ; MURAWSKY, Michael8 ; KLINK-ALAKL, May8 ; HUDEC, Marcus9 ; DITTRICH, Christian1 2
[1] Applied Cancer Research-Institution for Translational Research Vienna (ACR-ITR VIEnna), Vienna, Austria
[2] Ludwig Boltzmann-Institute for Applied Cancer Research (LBI-ACR VIEnna), Vienna, Austria
[3] Division of Medical Oncology and Radiotherapy, Universitaire Ziekenhuis Ku Leuven, Herestraat 49, 3000 Leuven, Belgium
[4] Department of Medical Oncology, Institut Curie, 26, rue d'Ulm, 75231 Paris, France
[5] Centre René Huguenin, 35, rue Dailly, 92211 Saint-Cloud, France
[6] Imperial College, Division of Surgery, Ccb Cancer Medicine, Ducane Road, London, W120NN, United Kingdom
[7] Department of Oncology, Radiumhemmet, Karolinska University Hospital, 17176 Stockholm, Sweden
[8] SanofiAventis, 46 Quai.de la Râpée, 75601 Paris, France
[9] Institute of Scientific Computing, University of Vienna, Universitätsstrasse 5, 1010 Vienna, Austria - Source
Journal of cancer research and clinical oncology. 2008, Vol 134, Num 2, pp 125-135, 11 p ; ref : 1 p.3/4
- CODEN
- JCROD7
- ISSN
- 0171-5216
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- Springer, Berlin
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- Anthracycline resistance Docetaxel Fluid retention Metastatic breast cancer Second-line chemotherapy
- Keyword (fr)
- Anthracyclines Anticancéreux Cancer du sein Docétaxel Essai clinique phase II Homme Métastase Résistance Second cancer Stade avancé Traitement de deuxième intention Antimitotique Cancer Dérivé du taxane Pathologie de la glande mammaire Tumeur maligne
- Keyword (en)
- Anthracyclins Antineoplastic agent Breast cancer Docetaxel Phase II trial Human Metastasis Resistance Second cancer Advanced stage Second line treatment Antimitotic Cancer Taxane derivatives Mammary gland diseases Malignant tumor
- Keyword (es)
- Antraciclinas Anticanceroso Cáncer del pecho Docetaxel Ensayo clínico fase II Hombre Metástasis Resistencia Segundo cáncer Estadio avanzado Tratamiento de segunda línea Antimitótico Cáncer Taxane derivado Glándula mamaria patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19981524
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s00432-007-0259-0 
https://dx.doi.org/10.1007/s00432-007-0259-0
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00432-007-0259-0\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:48:\"Journal of cancer research and clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. cancer res. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"134\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"135\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-5216\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BAUR\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Martina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:21:\"VAN OOSTEROM, Allan T\";i:1;s:17:\"DIERAS, Veronique\";i:2;s:22:\"TUBIANA-HULIN, Michele\";i:3;s:19:\"COOMBES, R. Charles\";i:4;s:16:\"HATSCHEK, Thomas\";i:5;s:17:\"MURAWSKY, Michael\";i:6;s:16:\"KLINK-ALAKL, May\";i:7;s:13:\"HUDEC, Marcus\";i:8;s:19:\"DITTRICH, Christian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCROD7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00432-007-0259-0\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:48:\"Journal of cancer research and clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. cancer res. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"134\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"135\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-5216\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BAUR\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Martina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:21:\"VAN OOSTEROM, Allan T\";i:1;s:17:\"DIERAS, Veronique\";i:2;s:22:\"TUBIANA-HULIN, Michele\";i:3;s:19:\"COOMBES, R. Charles\";i:4;s:16:\"HATSCHEK, Thomas\";i:5;s:17:\"MURAWSKY, Michael\";i:6;s:16:\"KLINK-ALAKL, May\";i:7;s:13:\"HUDEC, Marcus\";i:8;s:19:\"DITTRICH, Christian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCROD7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00432-007-0259-0\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00432-007-0259-0\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:48:\"Journal of cancer research and clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. cancer res. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"134\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"135\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-5216\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BAUR\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Martina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:21:\"VAN OOSTEROM, Allan T\";i:1;s:17:\"DIERAS, Veronique\";i:2;s:22:\"TUBIANA-HULIN, Michele\";i:3;s:19:\"COOMBES, R. Charles\";i:4;s:16:\"HATSCHEK, Thomas\";i:5;s:17:\"MURAWSKY, Michael\";i:6;s:16:\"KLINK-ALAKL, May\";i:7;s:13:\"HUDEC, Marcus\";i:8;s:19:\"DITTRICH, Christian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCROD7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00432-007-0259-0\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:48:\"Journal of cancer research and clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. cancer res. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"134\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"135\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-5216\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BAUR\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Martina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:21:\"VAN OOSTEROM, Allan T\";i:1;s:17:\"DIERAS, Veronique\";i:2;s:22:\"TUBIANA-HULIN, Michele\";i:3;s:19:\"COOMBES, R. Charles\";i:4;s:16:\"HATSCHEK, Thomas\";i:5;s:17:\"MURAWSKY, Michael\";i:6;s:16:\"KLINK-ALAKL, May\";i:7;s:13:\"HUDEC, Marcus\";i:8;s:19:\"DITTRICH, Christian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCROD7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s00432-007-0259-0\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:9:\"\u0000*\u0000jtitle\";s:48:\"Journal of cancer research and clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:26:\"J. cancer res. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:3:\"134\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"125\";s:8:\"\u0000*\u0000epage\";s:3:\"135\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0171-5216\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BAUR\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Martina\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:21:\"VAN OOSTEROM, Allan T\";i:1;s:17:\"DIERAS, Veronique\";i:2;s:22:\"TUBIANA-HULIN, Michele\";i:3;s:19:\"COOMBES, R. Charles\";i:4;s:16:\"HATSCHEK, Thomas\";i:5;s:17:\"MURAWSKY, Michael\";i:6;s:16:\"KLINK-ALAKL, May\";i:7;s:13:\"HUDEC, Marcus\";i:8;s:19:\"DITTRICH, Christian\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JCROD7\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A phase II trial of docetaxel (Taxotere\u00ae) as second-line chemotherapy in patients with metastatic breast cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Berlin\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
